格隆汇4月11日丨复星医药(02196.HK)公告,于2025年4月11日,公司与复星高科技、李凡以及关晓晖订立股权转让协议,据此,公司同意出售、且复星高科技、李凡以及关晓晖同意分别以现金对价人民币13,993,682元、人民币12,497,806元、人民币48,254元购买上海复健29.00%、25.90%、0.10%的股权。本次转让完成后,公司持有上海复健的股权比例将由本次转让前的100%降至...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.